Terumo Corporation (TYO: 4543)

Market Cap	4.50T
Revenue (ttm)	986.67B
Net Income (ttm)	119.49B
Shares Out	1.48B
EPS (ttm)	80.41
PE Ratio	37.78
Forward PE	30.94
Dividend	26.00 (0.85%)
Ex-Dividend Date	Mar 28, 2025

Volume	2,117,400
Open	3,066.00
Previous Close	3,036.00
Day's Range	3,043.00 - 3,097.00
52-Week Range	2,134.00 - 3,182.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4543

Financial Performance

In 2023, Terumo's revenue was 921.86 billion, an increase of 12.39% compared to the previous year's 820.21 billion. Earnings were 106.37 billion, an increase of 19.09%.